GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I'd seen in ...

In a report released today, Florent Cespedes from Bernstein maintained a Buy rating on GlaxoSmithKline (GSK – Research Report), with a price ...

Deutsche Bank analyst Emmanuel Papadakis maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

The benchmark U.S. 10-year Treasury bond yield is near 4.5%. The yield was headed toward the key 5% threshold in April on hotter-than-expected inflation data, but turned lower after the May ...

This investing style is all about taking advantage of upward or downward trends in a stock's price or earnings outlook ... the better. GSK has three segments: Specialty Medicines (HIV, Oncology ...

A study of over 280,000 adults found that the shingles vaccine reduced dementia risk by 20%, with a stronger effect in women.

GSK shares are trading cheaply and offering potential passive income. So is this FTSE 100 stock a no-brainer buy for my ...

Learn more about whether Corcept Therapeutics Incorporated or GSK plc is a better investment based on AAII's A+ Investor ...

GSK’s share price has fallen a long way from its one-year high, which has only increased the major undervaluation I’d seen in the stock before that. When investing, your capital is at risk.

It doesn't matter your age or experience: taking full advantage of the stock market ... and Price/Cash Flow to highlight the most attractive and discounted stocks. GSK has three segments ...